Table 1 Baseline characteristics
Control (n = 779) | MVA (n = 191) | p-value | |
|---|---|---|---|
Age, years | 52.0 ± 10.9 | 57.7 ± 9.1 | < 0.001 |
Female gender, n (%) | 440 (56.5) | 132 (69.1) | 0.001 |
Body mass index, kg/m2 | 23.3 ± 6.0 | 24.0 ± 6.6 | 0.221 |
Systolic BP, mmHg | 127.1 ± 18.4 | 129.1 ± 16.6 | 0.262 |
Diastolic BP, mmHg | 78.8 ± 12.6 | 78.0 ± 12.4 | 0.514 |
Smoking, n (%) | 133 (25.5) | 24 (17.9) | 0.070 |
Alcohol, n (%) | 179 (34.4) | 30 (22.4) | 0.009 |
Hypertension, n (%) | 141 (26.7) | 57 (37.3) | 0.019 |
Diabetes mellitus, n (%) | 80 (14.4) | 27 (19.7) | 0.146 |
Dyslipidemia, n (%) | 212 (40.1) | 69 (51.9) | 0.018 |
Hyperthyroidism, n (%) | 51 (9.6) | 9 (6.8) | 0.510 |
Medication | |||
Aspirin, n (%) | 117 (15.0) | 34 (17.8) | 0.422 |
RAS blocker, n (%) | 91 (11.7) | 33 (17.3) | 0.110 |
Beta blocker, n (%) | 69 (8.9) | 25 (13.1) | 0.141 |
Calcium channel blocker, n (%) | 97 (12.5) | 31 (16.2) | 0.314 |
Diuretics, n (%) | 21 (2.7) | 6 (3.1) | 0.769 |
Nitrates, n (%) | 79 (10.1) | 17 (8.9) | 0.871 |
Statin, n (%) | 83 (10.7) | 22 (11.5) | 0.218 |